Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
3(50%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
2
33%
Ph not_applicable
4
67%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution6 total trials
Phase 3Large-scale testing
2(33.3%)
N/ANon-phased studies
4(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

6

all time

Status Distribution
Active(4)
Completed(2)

Detailed Status

Active, not recruiting2
Completed2
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
3
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 32 (33.3%)
N/A4 (66.7%)

Trials by Status

not_yet_recruiting117%
recruiting117%
active_not_recruiting233%
completed233%

Recent Activity

Clinical Trials (6)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
6